Raczkowska Adrianna, Arak Kinga, Jaworska Karolina
Department of Molecular Microbiology, Institute of Microbiology, Faculty of Biology, University of Warsaw.
Postepy Biochem. 2024 Dec 2;70(4):508-521. doi: 10.18388/pb.2021_569. Print 2024 Dec 31.
The gut microbiota is an essential component of the proper functioning of the human body, as gut microorganisms and their metabolites strongly influence the host’s metabolism and immune functions. They also contribute to the biosynthesis of vitamins, production of gut hormones, maintenance of intestinal barrier integrity, protection against pathogens, as well as digestion and absorption of nutrients. There is increasing emphasis on the relationship between disturbances in gut microbiota composition and the onset of metabolic diseases such as obesity and type 2 diabetes. Understanding the significance of the microbiota in the course of these diseases, its composition, and activity may offer new approaches to their treatment. Increasing attention is being paid to individual species of gut bacteria, among which Akkermansia muciniphila holds a special position. A decreased number of this commensal bacterium in the gut is associated with many diseases, including obesity and diabetes.
肠道微生物群是人体正常运作的重要组成部分,因为肠道微生物及其代谢产物会强烈影响宿主的新陈代谢和免疫功能。它们还有助于维生素的生物合成、肠道激素的产生、维持肠道屏障的完整性、抵御病原体以及营养物质的消化和吸收。人们越来越重视肠道微生物群组成的紊乱与肥胖和2型糖尿病等代谢性疾病发病之间的关系。了解微生物群在这些疾病过程中的重要性、其组成和活性可能会为疾病治疗提供新方法。人们越来越关注肠道细菌的各个种类,其中嗜黏蛋白阿克曼氏菌占据特殊地位。肠道中这种共生细菌数量的减少与许多疾病有关,包括肥胖症和糖尿病。